Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.
Press releases published on October 15, 2025
October 15, 2025
Clene to Participate in a Panel Discussion at the Maxim Growth Summit
Indeterminate
GlobeNewswire
October 15, 2025
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
Indeterminate
GlobeNewswire
October 15, 2025
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025
Indeterminate
GlobeNewswire
October 15, 2025
Akari Therapeutics Announces $2.5 Million Registered Direct Offering
Indeterminate
GlobeNewswire
October 15, 2025
Sienna Announces October Dividend
Indeterminate
GlobeNewswire
October 15, 2025
Boehringer Ingelheim advances cancer antibody-drug conjugate portfolio with asset from AimedBio
Indeterminate
GlobeNewswire
October 15, 2025
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25
Indeterminate
GlobeNewswire
October 15, 2025
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29
Indeterminate
GlobeNewswire
October 15, 2025
SCYNEXIS and GSK Resolve Their Disagreement Related to the Restart of the Phase 3 MARIO Study
Indeterminate
GlobeNewswire
October 15, 2025
Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
Indeterminate
GlobeNewswire
October 15, 2025
Beacon Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference
Indeterminate
GlobeNewswire
October 15, 2025
Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119, Considering Combination Therapies
Indeterminate
GlobeNewswire
October 15, 2025
Turn Therapeutics Appoints Dr. Kent Kester to Board of Directors
Indeterminate
GlobeNewswire
October 15, 2025
Rezolute to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
October 15, 2025
Amarin to Report Third Quarter 2025 Financial Results and Host Conference Call on October 29, 2025
Indeterminate
GlobeNewswire
October 15, 2025
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
Indeterminate
GlobeNewswire
October 15, 2025
Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome
Indeterminate
GlobeNewswire
October 15, 2025
Minovia Therapeutics קיבלה את אישור תרופת היתום של ה-FDA עבור MNV-201 בתסמונת מיאלודיספלסטית
Indeterminate
GlobeNewswire